INSIDE THE SECRET HQ OF ONE OF NEURALINK'S BIGGEST COMPETITORS

Summary from the TLDR newsletter

Synchron's Stentrode brain-computer interface has been implanted in 10 people since 2019. The company differentiates itself with a minimally invasive implantation process: the Stentrode does not require drilling into the skull. It is instead inserted into a vein above the motor cortex, so it's near the brain but not directly on it. This article takes a look at the Stentrode and how it compares to Neuralink's N1 implant. It also looks at the wider industry and the state of other related technologies.